Effective Wednesday, April 29, 2026, Schistocyte Review (LAB1231565) will be available to order across all Corewell Health Laboratories Hematology Departments.
This new orderable supports alignment across Corewell Health regions by standardizing schistocyte assessment practices, ensuring high‑quality testing, and delivering a consistent patient care experience system‑wide.
We are pleased to announce the launch of the Myxoid Liposarcoma Panel by Fluorescence in situ Hybridization (FISH), now available for clinical ordering on Formalin-fixed, paraffin-embedded (FFPE) tissue.
The Myxoid Liposarcoma Panel by FISH includes:
These probes may also be ordered individually.
For additional clinical details or follow-up questions regarding this test, please use the contact us link above.
Effective October 10, 2025, Corewell Health Reference Laboratory West will implement an updated protocol for the Lupus Screen (LAB478). This change is designed to improve diagnostic accuracy for patients undergoing anticoagulant therapy, where false-positive or false-negative results can complicate clinical decision-making.
Effective December 2, 2024 at 08:00 AM, Corewell Health West Laboratory Coagulation Department will be updating the reference range for several assays. The following will be impacted by these changes:
APTT testing for the BCS XP analyzers will be updating to 22.0 – 27.0 seconds.
This will include the following tests:
Effective December 2, 2024 at 08:00 AM, the Corewell Health West and South Coagulation Departments will be updating the reference range of the Fibrinogen Level (LAB 314) to 190-450 mg/ dL.
Questions may be directed to the Coagulation Laboratory using the Contact Us link above.
As of January 26, 2024, for the following tests, the testing platform has changed from EliA Fluorescence Enzyme Immunoassay (FEIA) from Thermofisher to Multiplex Flow Immunoassay from Biorad. Please review the lab catalog for any changes to collection information or reference ranges.
• Anti-dsDNA Antibody
• Cyclic Citrullinated Peptide (CCP) Antibody
• Celiac Antibody Cascade
• Tissue Transglutaminase Antibody
• Gliadin Antibodies
Monoclonal gammopathies are characterized by the secretion of a monoclonal protein or M-protein. A wide variety of conditions can produce an M-protein, and the initial screening and monitoring of these patients require an array of tests. Herein we described best practices for protein electrophoresis ordering at Corewell Health.